|
|
SPOT ON
|
|
Jupiter study: no expansion of indication for statins
Gabapentin (NEURONTIN): study data manipulated
|
|
|
NEW ON THE MARKET
|
|
Rifaximin (XIFAXAN) for traveler`s diarrhea?
|
|
|
THERAPY FROM A CRITICAL VIEWPOINT
|
|
Prevention with antioxidants: damage outweighs benefit
|
|
|
a-t READERS' QUESTIONS AND COMMENTS
|
|
Aspirin (ASS) for primary prevention in all diabetics?
|
|
|
IN BRIEF
|
|
More agents against head lice tested by the German Federal Environmental Agency
|
|
Scientists criticize HPV-vaccination
On the role of opinion leaders
|
|
|
CURRENT ADR NETWORK REPORT
|
|
CNS-damage due to strontium ranelate (PROTELOS)
|
|
|
SIDE EFFECTS
|
|
Efalizumab (RAPTIVA): progressive multifocal leukoencephalopathy (PML)
|
|